STK17B and metabolic dysfunction-associated steatotic liver disease: Although DRAK2 undoubtedly plays an extremely important role in the early stages of NAFLD development, because of the limitations of research techniques and challenges in clinical application, the mechanisms underlying the promotion of DRAK2 expression by ROS remain to be investigated.